painless gastroenteroscopy
Conditions
Interventions
Cyclopol group:Cyclopol sedation
remimazolam:remimazolam sedation
CR group:ciprofol combined with remimazolam sedation
Sponsors
The First Affiliated Hospital of Yangtze University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)Patients with accurate and complete clinical data who undergo both gastroscopy and enteroscopy; (2) Age 18-65 years old, ASA grade I ~ II, BMI 18~30kg/m2; (3) No dysfunction of liver and kidney and other important organs, no shock and cardiopulmonary dysfunction; (4) Tolerable to intravenous anesthesia and gastroscopy (5)Estimated surgical time within 30 minutes(6)Ability to read and understand; Informed and willing to participate in this study.
Exclusion criteria
Exclusion criteria: (1) Patients with obvious respiratory and circulatory dysfunction and abnormal liver and kidney function before operation; (2) Patients with severe neuropsychiatric diseases; (3) People with infectious diseases; (4) Taking benzodiazepines or opioids intermittently within 1 month or nearly 3 months; (5) Those who are allergic or taboo to benzodiazepines, opioids, propofol,Ciprofol, flumazenil, naloxone and other drugs and their drug components; (6) Patients who are judged to have difficulty in respiratory tract management: modified Mallampati score III or above.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall incidence of adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events during the trial;Changes of vital signs during the test; | — |
Countries
China
Contacts
Public ContactRui Xia
The First Affiliated Hospital of Yangtze University
Outcome results
None listed